Phathom Pharmaceuticals, Inc. (PHAT)
NMS – Real Time Price. Currency in USD
10.72
+0.38 (3.68%)
At close: Jun 26, 2026, 4:00 PM EDT
10.66
-0.06 (-0.56%)
After-hours: Jun 26, 2026, 7:48 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
10.72
+0.38 (3.68%)
At close: Jun 26, 2026, 4:00 PM EDT
10.66
-0.06 (-0.56%)
After-hours: Jun 26, 2026, 7:48 PM EDT
No Data
There are no news for this stock.
Total debt $547.2M significantly exceeds cash reserves ($180.9M), raising financial stability concerns
Total current assets $276.6M exceed Total current liabilities $125.0M, highlighting excellent liquidity
Debt-to-equity ratio (-1.6) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-1.0x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$15.7M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.21 | 6.05 | 10 | |
| Quick ratio | 2.16 | 5.63 | 10 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 1.79 | 1.04 | 1.0 | |
| Interest coverage | -0.98 | -16.91 | 1.0 | |
| Weighted average score | 4.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 682K | 55M | 175M | 205M |
| Gross Profit | -620K | -60K | 47M | 153M | 174M |
| Operating Income | -172M | -167M | -277M | -160M | -97M |
| Net Income | -198M | -202M | -334M | -221M | -157M |
| EBITDA | -172M | -167M | -277M | -159M | -96M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 87.27 | 80.27 | 10 |
| Next quarter | 88.39 | 87.36 | 10 |
| Current year | 90.75 | 79.43 | 10 |
| Next year | 61.65 | 291.03 | 10 |
| Weighted average score | 10 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 1.25 | -43.59 | -27.58 | -208.72 | 1.5 |
| Y/Y | 104.43 | 67.8 | 71.76 | 81.51 | 10 |
| 3y average | 3072.47 | -11.31 | 10.1 | -16.2 | 4.8 |
| 5y average | 2243.08 | -16.56 | 0.05 | -31.65 | 3.5 |
| Weighted average score | 5.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |